Company news

Zhejiang Chengyi Pharmaceutical Co. Ltd. news in 2026

Zhejiang Chengyi Pharmaceutical Co. Ltd.'s news releases, calls and decks from 2026, newest first.

View company

(603811)"Zhejiang Cheng Yi Pharmaceutical Co., Ltd."Report for Q3 2026

October 28, 2026

(603811)"Zhejiang Cheng Yi Pharmaceutical Co., Ltd."Announcement on Key Operating Data for Q3 2026

October 28, 2026

(603811)"Zhejiang Cheng Yi Pharmaceutical Co., Ltd."Announcement on Results of Shareholding Reduction by Director and Senior Executive

October 22, 2026

Announcement on Results of Shareholding Reduction by Senior Executive

September 30, 2026

Announcement on a Subsidiary's Receipt of Drug GMP Compliance Inspection Results

September 28, 2026

Announcement on Outline of the 2026 Semi-annual Performance Briefing

September 17, 2026

Announcement on Satisfaction of Unlocking Conditions for the 1st Unlocking Period under the 2025 Employee Stock Ownership Plan

September 15, 2026

Announcement on Convening the 2026 Semi-annual Performance Briefing

September 10, 2026

Announcement on Resolutions of the 6th Meeting of the 5th Board of Directors

August 26, 2026

Announcement on Shareholding Reduction Plan for Directors and Senior Management Members

June 30, 2026

Announcement on Progress in Providing Guarantee for Subsidiary

June 22, 2026

Announcement on Implementation of Dividend Distribution for 2025

June 18, 2026

Announcement on Results of GMP Compliance Inspection Concerning Drugs

June 4, 2026

Announcement on Outline of the Performance Briefing for 2025 and Q1 2026

May 22, 2026

Announcement on Resolutions of the 2025 Annual General Meeting

May 19, 2026

Announcement on Convening Performance Briefing for 2025 and Q1 2026

May 14, 2026

Announcement on Remunerations for Directors and Senior Management Members in 2025 and 2026 Remuneration Plan

April 23, 2026

Announcement on Selection of Products for Continuation Procurement Under National Procurement Scheme After Agreement Expiry

February 10, 2026